English Journal

Enhanced anti-tumor efficacy of paclitaxel with PEGylated lipidic nanocapsules in presence of curcumin and poloxamer: In vitro and in vivo studies.

Anwar M1, Akhter S2, Mallick N3, Mohapatra S3, Zafar S3, Rizvi MM4, Ali A3, Ahmad FJ5.
Pharmacological research.Pharmacol Res.2016 Aug 19;113(Pt A):146-165. doi: 10.1016/j.phrs.2016.08.025. [Epub ahead of print]
Cancer chemotherapeutic drug containing PEGylated lipidic nanocapsules (D-LNCs) were formulated by the controlled addition of organic phase (combined solution of paclitaxel and curcumin in a mixture of oleic acid and MPEG2000-DSPE (90:2.5 molar ratio) in acetone) to the aqueous phase (consist of Pol
PMID 27546165

Extraction and derivatization of Leucaena leucocephala (Lam.) galactomannan: Optimization and characterization.

Mittal N1, Mattu P1, Kaur G2.
International journal of biological macromolecules.Int J Biol Macromol.2016 Aug 1;92:831-841. doi: 10.1016/j.ijbiomac.2016.07.046. [Epub ahead of print]
Water soluble gums also known as hydrocolloids are increasingly finding applications in the pharmaceutical and food industry due to their versatile functional properties. They possess considerable use in food and pharmaceutical industries as emulsifying, thickening and gelling agents. In the present
PMID 27492556

Preparation, characterization, and in vivo evaluation of valsartan porous matrices using emulsion solvent evaporation technique.

Babu GK1, Babu PS1, Khagga M2.
International journal of pharmaceutical investigation.Int J Pharm Investig.2016 Jul-Sep;6(3):169-79. doi: 10.4103/2230-973X.187345.
INTRODUCTION: Valsartan is a type II Biopharmaceutics Classification System (BCS) classified drug. The poor aqueous solubility restricts its use in developing sustained or controlled release systems for the treatment of chronic hypertensive conditions. The present investigation was conducted with an
PMID 27606260

「腎血管」